Chronotropic Modulation of the Source-Sink Relationship of Sinoatrial-Atrial Impulse Conduction and Its Significance to Initiation of AF: A One-Dimensional Model Study.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4502286)

Published in Biomed Res Int on July 01, 2015

Authors

Francesca Cacciani1, Massimiliano Zaniboni2

Author Affiliations

1: Department of Life Sciences, University of Parma, Parco Area delle Scienze 11A, 43124 Parma, Italy.
2: Department of Life Sciences, University of Parma, Parco Area delle Scienze 11A, 43124 Parma, Italy ; Center of Excellence for Toxicological Research (CERT), Department of Clinical and Experimental Medicine, University of Parma, Via Gramsci 14, 43126 Parma, Italy.

Articles cited by this

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J (2006) 6.31

Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ Res (1997) 4.86

Sinoatrial nodal cell ryanodine receptor and Na(+)-Ca(2+) exchanger: molecular partners in pacemaker regulation. Circ Res (2001) 4.42

Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol (2008) 4.01

Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev (2007) 3.75

Synergism of coupled subsarcolemmal Ca2+ clocks and sarcolemmal voltage clocks confers robust and flexible pacemaker function in a novel pacemaker cell model. Am J Physiol Heart Circ Physiol (2009) 2.89

New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation (2007) 2.89

The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res (2001) 2.41

Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest (2011) 2.38

The contribution of the 'pacemaker' current (if) to generation of spontaneous activity in rabbit sino-atrial node myocytes. J Physiol (1991) 2.12

Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation (2004) 1.97

Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation (2003) 1.86

Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs (2004) 1.85

L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation (2004) 1.85

Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs. J Am Coll Cardiol (2004) 1.79

Computer three-dimensional reconstruction of the sinoatrial node. Circulation (2005) 1.72

Blinded test in isolated female rabbit heart reliably identifies action potential duration prolongation and proarrhythmic drugs: importance of triangulation, reverse use dependence, and instability. J Cardiovasc Pharmacol (2003) 1.71

Distribution of atrial and nodal cells within the rabbit sinoatrial node: models of sinoatrial transition. Circulation (1998) 1.68

A model of the action potential and underlying membrane currents in a rabbit atrial cell. Am J Physiol (1996) 1.55

Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine. J Gen Physiol (2002) 1.52

Sinoatrial node electrical activity modulates pulmonary vein arrhythmogenesis. Int J Cardiol (2014) 1.45

Propagation through electrically coupled cells. How a small SA node drives a large atrium. Biophys J (1986) 1.38

Kir3-based inward rectifier potassium current: potential role in atrial tachycardia remodeling effects on atrial repolarization and arrhythmias. Circulation (2006) 1.26

Funny current downregulation and sinus node dysfunction associated with atrial tachyarrhythmia: a molecular basis for tachycardia-bradycardia syndrome. Circulation (2009) 1.23

Electrophysiologic effects of adenosine in patients with supraventricular tachycardia. Circulation (1999) 1.23

Bradycardic and proarrhythmic properties of sinus node inhibitors. Mol Pharmacol (2005) 1.16

An updated computational model of rabbit sinoatrial action potential to investigate the mechanisms of heart rate modulation. J Physiol (2012) 1.15

Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res (2002) 1.15

Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation. Circ Res (1997) 1.12

Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model. Circulation (2014) 1.11

Complex interactions between the sinoatrial node and atrium during reentrant arrhythmias in the canine heart. Circulation (2010) 1.10

Origin and pharmacological response of atrial tachyarrhythmias induced by activation of mediastinal nerves in canines. Auton Neurosci (2005) 1.06

Conduction barriers and pathways of the sinoatrial pacemaker complex: their role in normal rhythm and atrial arrhythmias. Am J Physiol Heart Circ Physiol (2012) 1.04

Modulation of rabbit sinoatrial node activation sequence by acetylcholine and isoproterenol investigated with optical mapping technique. Acta Physiol (Oxf) (2009) 1.02

Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials. Heart (2014) 1.02

Drug-induced atrial fibrillation. Drugs (2012) 1.01

One-dimensional rabbit sinoatrial node models: benefits and limitations. J Cardiovasc Electrophysiol (2003) 1.00

The role of connexin40 in atrial fibrillation. Cardiovasc Res (2009) 0.99

Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations. Br J Pharmacol (1995) 0.99

Role of the input/output relation of sinoatrial myocytes in cholinergic modulation of heart rate variability. J Cardiovasc Electrophysiol (2000) 0.94

Drug-induced atrial fibrillation. J Am Coll Cardiol (2004) 0.94

Gap junctional channels in adult mammalian sinus nodal cells. Immunolocalization and electrophysiology. Circ Res (1992) 0.90

Atrial selectivity of antiarrhythmic drugs. J Physiol (2013) 0.89

Electrical interactions between a rabbit atrial cell and a nodal cell model. Am J Physiol (1998) 0.87

Cardiovascular drugs. Dofetilide. Circulation (2000) 0.85

Connexin40 abnormalities and atrial fibrillation in the human heart. J Mol Cell Cardiol (2014) 0.84

Onset of atrial arrhythmias elicited by autonomic modulation of rabbit sinoatrial node activity: a modeling study. Am J Physiol Heart Circ Physiol (2011) 0.83

Role of sinoatrial node architecture in maintaining a balanced source-sink relationship and synchronous cardiac pacemaking. Front Physiol (2014) 0.81

Interatrial conduction in the mechanisms of atrial fibrillation: from anatomy to cardiac signals and new treatment modalities. Europace (2007) 0.81

Electrotonic modulation of electrical activity in rabbit atrioventricular node myocytes. Am J Physiol (1997) 0.81

Beat-to-beat cycle length variability of spontaneously beating guinea pig sinoatrial cells: relative contributions of the membrane and calcium clocks. PLoS One (2014) 0.80

Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablation. Europace (2009) 0.79

Effect of verapamil on immediate recurrence of atrial fibrillation. J Cardiovasc Electrophysiol (2000) 0.78

Are calcium antagonists proarrhythmic? J Hypertens (1997) 0.78

Phase response curve based model of the SA node: simulation by two-dimensional array of pacemaker cells with randomly distributed cycle lengths. Med Biol Eng Comput (1999) 0.77

Dofetilide: a new pure class III antiarrhythmic agent. Am Heart J (2000) 0.76

Clinical study of the acute effects of intravenous nifekalant on the defibrillation threshold in patients with persistent and paroxysmal atrial fibrillation. Circ J (2008) 0.76

Conventional and novel drug therapeutics to relief myocardial ischemia. Cardiovasc Drugs Ther (2010) 0.76